Khan Farah, Ali S, Ganie B A, Rubab I
Department of Biochemistry, Jamia Hamdard (Hamdard University), Hamdard Nagar, New Delhi, India.
Methods Find Exp Clin Pharmacol. 2009 Oct;31(8):513-22. doi: 10.1358/mf.2009.31.8.1419719.
This study investigated the immunopotentiating effect of Khamira Marwarid (KM), an herbo-mineral Unani preparation, in an animal model. KM was administered to mice orally at a dose level of 2 g/kg body weight for 5, 10, 15 or 30 days, following which the animals were sacrificed for hematology and immune function testing, including lymphoid organ weight and cellularity. The group of animals receiving KM showed a significant increase (P < 0.05) in the relative organ (spleen and thymus) weight. Cellularity of the spleen and bone marrow also increased significantly (P < 0.01). Groups receiving KM for 10 and 15 days showed an increase in hemoglobin, red blood cells (RBCs) and total white blood cells (WBCs) (P < 0.01). The humoral immune response, evaluated by the plaque-forming cell (PFC) assay after challenging the mice with goat RBCs, was better in all treated groups when compared to controls. Maximum hemagglutination titer was obtained in mice treated with KM for 15 days. Ovalbumin-specific serum IgG levels in the treated mice also increased significantly (P < 0.01), suggesting an immunopotentiating effect for the preparation. Administration of KM resulted in elevated levels of IgG2a and IgG2b. A comparison of anti-ovalbumin IgE and IgG was also done; anti-ovalbumin IgE decreased, with a concomitant increase in anti-ovalbumin IgG. Administration of KM for 10 or 15 days elicited an increase in the delayed-type hypersensitivity (DTH) response. Taken together, the results suggest an immunostimulatory effect for KM through a mechanism leading to a Th1-dominant immune state.
本研究在动物模型中调查了草药-矿物类尤那尼制剂卡米拉·马尔瓦里德(KM)的免疫增强作用。以2 g/kg体重的剂量水平给小鼠口服KM,持续5、10、15或30天,之后处死动物进行血液学和免疫功能检测,包括淋巴器官重量和细胞数量。接受KM的动物组脾脏和胸腺等相对器官重量显著增加(P<0.05)。脾脏和骨髓的细胞数量也显著增加(P<0.01)。接受KM治疗10天和15天的组血红蛋白、红细胞(RBC)和总白细胞(WBC)增加(P<0.01)。在用山羊红细胞攻击小鼠后通过空斑形成细胞(PFC)试验评估的体液免疫反应,与对照组相比,所有治疗组均更好。用KM治疗15天的小鼠获得最大血凝滴度。治疗小鼠中卵清蛋白特异性血清IgG水平也显著增加(P<0.01),表明该制剂具有免疫增强作用。给予KM导致IgG2a和IgG2b水平升高。还对抗卵清蛋白IgE和IgG进行了比较;抗卵清蛋白IgE降低,同时抗卵清蛋白IgG增加。给予KM 10天或15天引起迟发型超敏反应(DTH)增加。综上所述,结果表明KM通过导致Th1主导免疫状态的机制具有免疫刺激作用。